Back

The Lancet

16 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Clinical and virological characteristics of critically ill patients with influenza in France during the 2025/26 season, marked by the emergence of influenza A(H3N2) clade K
2026-02-28 intensive care and critical care medicine 10.64898/2026.02.20.26346693
#1 (1.3%)
Show abstract

ImportanceRecent reports have highlighted an intense influenza activity related to the circulation of the influenza A(H3N2) subclade k variant. There is no data available on the impact of the emergence of H3N2 subclade k on the severity of the 2025-2026 epidemic or on the clinical phenotype of patients requiring admission to the intensive care unit (ICU). ObjectiveTo compare the clinical presentation, hospital mortality and virological characteristics of patients with laboratory-confirmed influ...

2
Outcomes of Venom-Induced Consumption Coagulopathy Following Snakebite Envenoming in Sudan: A Cohort Study
2026-01-27 toxicology 10.64898/2026.01.26.26344815
#1 (1.1%)
Show abstract

BackgroundSnakebite envenoming (SBE) remains a major neglected tropical disease in Sudan. Venom-induced consumption coagulopathy (VICC) is the most frequent and fatal systemic complication, particularly following envenoming by hemotoxic Echis species. Robust clinical data on VICC in Sudan are limited. MethodsWe conducted a prospective hospital-based cohort study at Sinja Teaching Hospital, Sennar state, Sudan, from March to September 2022. All patients admitted with SBE were enrolled. VICC was ...

3
Prevalence of 406 rare diseases by ethnicity and their associated COVID-19 infection burden: A national cross-sectional study of 62.5 million people in England
2026-01-16 public and global health 10.64898/2026.01.13.26344068
Top 0.1% (0.9%)
Show abstract

BackgroundThe COVID-19 pandemic disproportionately affected vulnerable populations, including individuals with rare diseases (RDs) and, in the general population, those from ethnic minority backgrounds. However, the intersectional risk, and how these vulnerabilities combine, is poorly understood. A comprehensive baseline map of RD prevalence by granular ethnicity is required to investigate the pandemics true impact on these complex patient groups. MethodsThis study had two aims: (1) to generate...

4
The Health Interventions Impact Calculator (HIIC): scaling up web-based access to proportional multistate lifetable analyses of avoidable burden, health gain and economic impacts.
2026-02-03 epidemiology 10.64898/2026.02.01.26345324
Top 0.1% (0.9%)
Show abstract

Health metrics and modelling capacity have expanded to address present burden and burden attributable to risk factors in the past. There remains a gap in accessible tools that estimate avoidable burden; --that is, the future health and economic impacts of preventive and treatment interventions. This paper describes and demonstrates the Health Interventions Impact Calculator (HIIC), a free web-based analysis and visualisation tool that allows for rapid estimation of the future health and economi...

5
The Hidden Burden of Mortality Across the Spectrum of ICD-10 Conditions in Australia: A Multiple Cause of Death Analysis
2026-02-09 epidemiology 10.64898/2026.02.07.26345820
Top 0.1% (0.9%)
Show abstract

BackgroundDeath certificates record both an underlying cause and contributing conditions, yet mortality statistics predominantly report only the underlying cause. We quantify this "hidden burden" across all ICD-10 conditions in Australian mortality data using the multiple-to-underlying ratio (MUR): total death certificate mentions divided by underlying cause deaths. MethodsWe analysed Australian Bureau of Statistics Causes of Death 2023 data (N = 187,268 registered deaths) to compute the ratio ...

6
Diagnostic Potential for IgM Antibody Detection by the DPP Syphilis TnT Assay in Neonates at Risk for Congenital Syphilis
2026-01-06 infectious diseases 10.64898/2026.01.05.26343454
Top 0.2% (0.9%)
Show abstract

BackgroundNeonatal IgM antibodies reflect an in-utero immune response to Treponema pallidum and may offer added diagnostic value. This study evaluated the test performance of treponemal IgM levels measured by the research-use-only (RUO) DPP Syphilis TnT point-of-care (POC) assay for CS risk stratification. MethodsConducted from May 2023 to May 2025, this study tested neonatal serum samples from infants born to mothers with syphilis using the DPP Syphilis TnT RUO POC assay, which reports trepone...

7
Longitudinal clustering of health behaviours and their association with multimorbidity: Evidence from Understanding Society (UKHLS)
2026-02-17 epidemiology 10.64898/2026.02.13.26346295
Top 0.2% (0.9%)
Show abstract

BackgroundSmoking, unhealthy nutrition, alcohol consumption, and physical inactivity (SNAP behaviours) are major risk factors for multimorbidity but are often studied in isolation. Using longitudinal data, Suhag et al. identified clusters of older adults (aged [≥]50) with common SNAP behaviour patterns and distinct sociodemographic profiles and multimorbidity prevalence; whether and how these patterns generalise across adulthood remains unclear. AimTo conceptually replicate Suhag et al. acro...

8
Health care resource consumption and corresponding economic burden in patients with acute cardiovascular diseases during the COVID-19 pandemic period
2026-01-02 health economics 10.64898/2025.12.31.25343267
Top 0.3% (0.8%)
Show abstract

BackgroundDuring the COVID-19 pandemic period, healthcare systems substantially reorganized their management of several diseases, including acute cardiovascular diseases (ACVD) such as heart failure, stroke, myocardial infarction, and pulmonary embolism. While previous studies have reported changes in hospitalization rates and clinical outcomes, the economic impact of the pandemic on healthcare expenditures for patients with ACVD remains poorly documented. This study aimed to quantify disruption...

9
Investigating the Effect of Climate and Air Pollution on Prescription Uptake in the England
2026-02-16 health policy 10.64898/2026.02.13.26346258
Top 0.3% (0.7%)
Show abstract

BackgroundClimate change is increasingly recognised as a threat to population health and healthcare systems, yet the effects of environmental variability on pharmaceutical prescribing remain poorly characterised in the UK. Using a wide array of open-source datasets, we examine the effect of environmental, geographic and socioeconomic factors on prescribing habits in England. MethodsWe linked monthly, practice-level prescribing data for England (2010-2025) to meteorological, air-quality, floodin...

10
Spatial Dynamics of Australia's Syphilis Surge: Geographic Clustering, Service Accessibility, and the Dual Epidemic, 2011 to 2024
2026-02-17 sexual and reproductive health 10.64898/2026.02.13.26346302
Top 0.4% (0.7%)
Show abstract

BackgroundAustralia is experiencing its worst syphilis epidemic in decades, driven by two distinct outbreaks -- a heterosexual epidemic disproportionately affecting Aboriginal and Torres Strait Islander communities in northern Australia, and a predominantly MSM-associated epidemic in urban centres. We examined the spatial dynamics of this dual epidemic, including geographic clustering, service accessibility associations, and COVID-19 impacts. MethodsWe analysed publicly available aggregate surv...

11
Active Surveillance for Heartland virus in North Carolina: Clinical and Genomic Epidemiology
2026-03-04 infectious diseases 10.64898/2026.02.27.26347100
Top 0.4% (0.7%)
Show abstract

BackgroundHeartland virus (HRTV) is an emerging tick-borne virus capable of causing severe illness and death. The burden of disease is likely underestimated due to limited seroprevalence studies, lack of commercially available diagnostic tests, and an overlapping clinical syndrome with more commonly diagnosed bacterial diseases such as spotted fever group rickettsiosis or ehrlichiosis. MethodsActive surveillance for Heartland virus disease was conducted at a large academic center from March to ...

12
Hospitalisation and mortality impact of shielding during 2020 in England: a transmission modelling evaluation using the OpenSAFELY platform
2025-12-17 epidemiology 10.64898/2025.12.12.25342168
Top 0.4% (0.7%)
Show abstract

BackgroundDuring the early phase of the Covid-19 pandemic in England, people with pre-existing conditions that put them at severe clinical risk if infected were advised to drastically reduce face-to-face contacts in a policy known as "shielding". The impact of this policy in preventing COVID-19 hospitalisations and deaths has not been evaluated at the national level using transmission-dynamic modelling. MethodsWith the approval of NHS England, we present a retrospective cohort evaluation of the...

13
Epidemiology and Characteristics of MPXV Clade I cases in the WHO European Region, 2024-2025
2025-12-18 epidemiology 10.64898/2025.12.17.25342473
Top 0.4% (0.7%)
Show abstract

BACKGROUNDOn 14 August 2024, WHO Director-General declared a public health emergency of international concern (PHEIC) following a sharp increase in mpox cases linked to the emergence of monkeypox virus (MPXV) clade Ib. We characterise imported and autochthonous cases of MPXV clade I reported in the WHO European Region since August 2024. METHODSBetween 14 August 2024 and 23 November 2025, we collected key information of MPXV clade I infections reported by member states of the WHO European Region...

14
Metabolic Basis of Post-Infectious Sequelae After Ebola Virus Disease
2026-01-06 infectious diseases 10.64898/2026.01.02.25343095
Top 0.5% (0.7%)
Show abstract

Ebola virus disease (EVD) survivors often present with clinical sequelae after acute disease resolution, called post-Ebola syndrome (PES). Why some survivors develop these sequelae and others do not is poorly defined. Altered metabolism has been noted in acute EVD but not studied in PES. We identified differential expression of metabolites involved in multiple metabolic pathways in EVD survivors with PES. This included the tricarboxylic acid cycle, amino acid, nucleotide, and short chain fatty a...

15
Mpox coinfections and clinical manifestation in Africa: a systematic review and meta-analysis
2026-02-09 infectious diseases 10.64898/2026.02.06.26345747
Top 0.5% (0.7%)
Show abstract

BackgroundAfrica continues to have a significant public health problem with mpox, where endemic transmission persists and overlaps with a high burden of other infectious diseases. Although their epidemiology and clinical impact are still poorly understood throughout the continent, coinfections with human immunodeficiency virus (HIV) and varicella-zoster virus (VZV) can affect the clinical picture, severity of the disease, and accuracy of the diagnosis. MethodsFollowing PRISMA criteria, we regis...

16
Projected population health, demographics, and associated healthcare resource requirements from 2025 to 2047: modelling study in England
2025-12-23 health economics 10.64898/2025.12.22.25342817
Top 0.6% (0.5%)
Show abstract

ObjectivesThere is a deficit of information available to guide longer-term healthcare planning in meeting health needs and ensuring financial sustainability. This study attempts to address this gap through projecting future population health state and demographics and associated healthcare resources required to satisfy expected demands over the next two decades. MethodsA mathematical model is developed for projecting a populations future age and health state, subject to births, deaths, immigrat...

17
High burden of maternal and congenital syphilis in Lima, Peru: an epidemiological analysis from 2023-2025
2026-03-05 epidemiology 10.64898/2026.03.04.26347675
Top 0.6% (0.5%)
Show abstract

ObjectiveCongenital syphilis remains a preventable cause of fetal and neonatal morbidity and mortality, despite the availability of inexpensive diagnostics and effective treatment. We aimed to evaluate the maternal and congenital syphilis burden at the Instituto Nacional Materno Perinatal, Perus national referral center for maternal and perinatal care. MethodsWe conducted a retrospective analysis of aggregated, de-identified surveillance data from January 2023 to December 2025. Maternal prevale...

18
Healthcare utilization among adults with co-occurring substance use and mental health disorders (2018-2023): A study based on All of Us program
2026-01-30 addiction medicine 10.64898/2026.01.28.26344935
Top 0.6% (0.5%)
Show abstract

BackgroundCo-occurring substance use and mental health disorders (COD) represent a growing public health concern, yet healthcare utilization studies with a large sample size remain limited. This study examined healthcare utilization patterns and sociodemographic correlates among COD adults using data from the All of Us Research Program (2018-2023). MethodsElectronic health record data were analyzed for adults aged [≥]18 years with confirmed diagnoses of substance use and mental health disord...

19
A model-based evaluation of the cost-effectiveness of paediatric and elderly vaccination against pneumococcal infection in England
2026-03-02 infectious diseases 10.64898/2026.02.26.26347158
Top 0.7% (0.4%)
Show abstract

Infection with pnuemococcus bacteria is generally mild but can be more severe in the young and elderly, causing invasive pneumococcal disease (IPD) and community-acquired pneumonia (CAP). Although paediatric pneumococcal conjugate vaccine (PCV) programmes and elderly pneumococcal polysaccharide vaccine (PPV) programmes have reduced cases, we estimate that pneumococcal infection still leads to direct health care costs of around {pound}68M and approximately 16 thousand QALY losses in England per y...

20
Diagnostic accuracy of five mpox lateral flow assays for antigen detection, the Democratic Republic of the Congo and Switzerland
2026-01-30 infectious diseases 10.64898/2026.01.28.26345023
Top 0.7% (0.4%)
Show abstract

BackgroundMpox has spread to 35 countries in Africa, yet many face challenges achieving nationwide PCR-based testing due to cost and limited access in remote and rural areas. Point-of-care antigen-based rapid diagnostic tests (AgRDTs) may help improve diagnostic access. ObjectivesTo evaluate the diagnostic accuracy of five mpox AgRDTs manufactured by Beijing Hotgen Biotech (China), Contipharma (Belgium), Hangzhou Testsea Biotechnology (China), Guangdong Wesail Biotech (China), and NG Biotech (F...